Literature DB >> 2903341

Laboratory techniques and neuroblastoma screening.

T Sawada.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2903341     DOI： 10.1016/s0140-6736(88)90545-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Fluctuation in the concentrations of vanillylmandelic acid and homovanillic acid in mass screening for neuroblastoma.

Authors:  M Nishi; H Miyake; T Takeda; K Yamashiro; N Takasugi; J Hanai; T Kawai
Journal:  Eur J Pediatr       Date:  1990-09       Impact factor: 3.183

2.  Poor prognosis neuroblastoma: is screening the answer?

Authors:  A W Craft; L Parker
Journal:  Br J Cancer Suppl       Date:  1992-08

3.  MYCN gene amplification is a powerful prognostic factor even in infantile neuroblastoma detected by mass screening.

Authors:  T Iehara; H Hosoi; K Akazawa; Y Matsumoto; K Yamamoto; S Suita; T Tajiri; T Kusafuka; E Hiyama; M Kaneko; F Sasaki; T Sugimoto; T Sawada
Journal:  Br J Cancer       Date:  2006-05-22       Impact factor: 7.640

4.  Effectiveness of nationwide screening program for neuroblastoma in Japan.

Authors:  Akinori Hisashige
Journal:  Glob J Health Sci       Date:  2014-04-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.